Moteur de recherche d’entreprises européennes

Conseils & Astuces
Nos pages FAQ tout sur la recherche en un clic et aperçu de la recherche avancée expliquent comment utiliser notre moteur de recherche.

Registre de Transparence de l'Union Européenne Eutr 18/04/2026 Registre de Transparence de l'Union Européenne

Vue d’ensemble

Texte

European Union Transparency Register Entry

Identification

  • Identification Code: 289777818743-24
  • Registration Date: 2015-09-10 16:35:12.759+00:00
  • Last Update Date: 2026-04-16 14:30:23.292+00:00

Organization Details

Head Office

  • Address:
    ?? Rue sans nom, 55216 Ingelheim, Allemagne
    , GERMANY
  • Phone: +49 6132770

EU Office

  • Address: Rue Marie de
    ?? Rue sans nom, 1000 Brussels, Allemagne
    , BELGIUM
  • Phone: +32 27733410

Goals

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,300 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com

Levels of Interest

  • European
  • Global
  • National
  • Sub-national

EU Legislative Proposals

Policies and Legislation in various areas, including EU Health and Pharmaceuticals (Human and Animal Health), EU Industrial Policy, EU Competitiveness Policy, EU Research Policy, EU Trade Policy, EU Environment Policy, EU Sustainability Policy

Communication Activities

None.

Inter or Unofficial Groupings

N/A

Members

  • Total Members: 4.0
  • FTEs: 2.0
  • Members by Percentage of Time:
    • 75% of time: 1 member
    • 50% of time: 2 members
    • 25% of time: 1 member
  • Information on Members: In 2025, Boehringer had 4 employees actively engaged in activities falling within the scope of the EU Register, spending a percentage of their time equivalent to a total of 2 full-time FTEs (75%, 50%, 50%, and 25% respectively.) Other Boehringer colleagues have been consulted on EU policy topics to support the EU office in its work, but their contributions amount to less than 10% of their time.

EP Accredited Number

2

Interests

  • Agriculture and rural development
  • Business and industry
  • Climate action
  • Competition
  • Customs
  • Digital economy and society
  • Economy, finance and the euro
  • Employment and social affairs
  • Environment
  • Food safety
  • International co-operation and development
  • Public health
  • Research and innovation
  • Single market
  • Taxation
  • Trade

Structure

Financial Data

Closed Year (2025-01-01 to 2025-12-01)

  • Total Costs: €2,000,000 - €2,249,999
  • Intermediaries:
    • Fleishman-Hillard: €200,000 - €299,999
  • Grants: None

Current Year

  • Intermediaries:
    • Fleishman-Hillard
  • Grants: None

Complementary Information

Boehringer Ingelheim's estimated total costs of annual activities related to the Transparency Register have been established based on the Transparency Register's Code of Conduct and implementing guidelines, as well as guidance provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA). They include operational costs of the Corporate Office, membership fees, consultancy fees, and contributions to third parties.

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Boehringer Ingelheim VRC GmbH, Ingelheim a. Rhein, Allemagne.